Citigroup’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.26M Sell
102,000
-374,000
-79% -$29.5M ﹤0.01% 1679
2025
Q4
$39M Hold
476,000
0.02% 738
2025
Q3
$35.7M Buy
476,000
+52,000
+12% +$3.88M 0.02% 777
2025
Q2
$31.4M Sell
424,000
-57,500
-12% -$4M 0.02% 753
2025
Q1
$38.9M Buy
481,500
+161,500
+50% +$13.9M 0.02% 659
2024
Q4
$25M Buy
320,000
+200,000
+167% +$17M 0.01% 835
2024
Q3
$11.3M Hold
120,000
0.01% 1269
2024
Q2
$9.35M Hold
120,000
0.01% 1282
2024
Q1
$10.9M Buy
+120,000
New +$9.98M 0.01% 1203

Other funds holding GEHC

Citigroup's GEHC Position: Q1 2026 in Review

Citigroup increased its GE HealthCare (GEHC) stake by 3.1% in Q1 2026, buying an estimated $1.53M and bringing the position to 648,314 shares worth $46.1M. The position accounts for 0.02% of the portfolio, ranked #673.

Citigroup first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $81.7M in Q3 2024. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Citigroup held 648,314 shares of GE HealthCare worth $46.1M as of Q1 2026.
  • Citigroup bought 19,391 GE HealthCare shares in Q1 2026, an estimated $1.53M.
  • GE HealthCare made up 0.02% of Citigroup's portfolio in Q1 2026, its #673 holding.
  • Citigroup first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Citigroup's GE HealthCare position peaked at $81.7M in Q3 2024.
  • 1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.